2010 Federal Register Search [2009] | FindingHealthOnline   

 
 
21CFR Portal
About My Drug
Alternative Medicine
Cancer Dictionary
Career Finder
CFR Portal
Company Websites
Controlled Substances
Diagnosis Tool
Disease Control/Prevention
Drug Safety
Encyclopedia (Medical)
Encyclopedia (Veterinary)
European Medicines Agency
Federal Register
FOI (Veterinary)
Free Prescriptions
Generic Drug Approvals
Generic Drug News
Health & Human Services
Health Organizations
Medical Encyclopedia
National Institutes of Health
Organizations by Symptom
Pharma Address Book
Pharma Careers
Pharma Company Websites
Pharma News
Regulatory Dictionary
Stocks (Pharmaceutical)
Thesaurus
Veterinary Encyclopedia
Veterinary FOI
Veterinary Medicine

Enter keywords or exact phrases enclosed in quotes.

Browse the past week's additions or search the cummulative index using the search window below.

Search for: Results per page:

Match: any search words all search words
Search results for: hydrocodone

17 results found.

2 pages of results.

... in the Federal Register on October 28, 2009, (74 FR 55586 ), Lin Zhi International Inc, 687 North Pastoria Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:-Drug Schedule-Tetrahydrocannabinols (7370). I 3, 4-Methylenedioxymethamphetamine (MDMA) I (7405). Cocaine (9041). II Oxycodone (9143). II Hydrocodone (9193). II Methadone (9250). II Dextropropoxyphene, bulk (non-dosage forms) II (9273). Morphine (9300). II-The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abuse testing. No comments or objections have been received. DEA has considered the factors in 21 USC 823 (a) and determined that the registration of Lin Zhi International Inc, to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Lin ...
URL: http://edocket.access.gpo.gov/2010/2010-4719.htm

... NTI-200 (9307). I Normorphine (9313). I Norlevorphanol (9634). I Amphetamine (1100). II Methamphetamine (1105). II Methylphenidate (1724). II Nabilone (7379). II Codeine (9050). II Diprenorphine (9058). II Etorphine HCl (9059). II Dihydrocodeine (9120). II Oxycodone (9143). II Hydromorphone (9150). II Diphenoxylate (9170). II Ecgonine (9180). II Hydrocodone (9193). II Levorphanol (9220). II Meperidine (9230). II Methadone (9250). II Methadone Intermediate (9254). II Metopon (9260). II Dextropropoxyphene, bulk (9273). II Morphine (9300). II Oripavine (9330). II Thebaine (9333). II Opium extracts (9610). II Opium fluid extract (9620). II Opium tincture (9630). II Opium, powdered (9639). II Opium, granulated (9640). II Levo-alphacetylmethadol (9648). II Oxymorphone ( ...
URL: http://edocket.access.gpo.gov/2010/2010-4717.htm

... Code of Federal Regulations (CFR ), this is notice that on February 19, 2010, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances in schedules I and II:-Drug Schedule-Tetrahydrocannabinols (7370). I Methylphenidate (1724). II Codeine (9050). II Dihydrocodeine (9120). II Oxycodone (9143). II Hydromorphone (9150). II Hydrocodone (9193). II Oripavine (9330). II Thebaine (9333). II Oxymorphone (9652). II Noroxymorphone (9668). II Fentanyl (9801). II-The company plans to manufacture the listed controlled substances in bulk for conversion and sale to dosage form manufacturers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33 (a). Any such written comments ...
URL: http://edocket.access.gpo.gov/2010/2010-6422.htm

... (1100). II Methamphetamine (1105). II Methylphenidate (1724). II Amobarbital (2125). II Pentobarbital (2270). II Secobarbital (2315). II 1-Phenylcyclohexylamine (7460). II Phencyclidine (7471). II Phenylacetone (8501). II 1-Piperidinocyclohexanecarbonitril (8603). II Cocaine (9041). II Codeine (9050). II Oxycodone (9143). II Hydromorphone (9150). II Benzoylecgonine (9180). II Ethylmorphine (9190). II Hydrocodone (9193). II Isomethadone (9226). II Meperidine (9230). II Meperidine intermediate-A (9232). II Meperidine intermediate-B (9233). II Methadone (9250). II Methadone intermediate (9254). II Dextropropoxyphene, bulk, (non-dosage II forms) (9273). Morphine (9300). II Thebaine (9333). II Levo-alphacetylmethadol (9648). II Oxymorphone (9652). II-The company plans to manufacture small quantities of the listed controlled substances to produce isotope labeled standards for drug testing and analysis ...
URL: http://edocket.access.gpo.gov/2010/2010-4723.htm

... I Dimethyltryptamine (7435). I 1 [1 (2-Thienyl) cyclohexyl] piperidine (7470). I Dihydromorphine (9145). I Normorphine (9313). I Amphetamine (1100). II Methamphetamine (1105). II Amobarbital (2125). II Phencyclidine (7471). II Phenylacetone (8501). II Cocaine (9041). II Codeine (9050). II Dihydrocodeine (9120). II Oxycodone (9143). II Hydromorphone (9150). II Ecgonine (9180). II Hydrocodone (9193). II Meperidine (9230). II Metazocine (9240). II Dextropropoxyphene, bulk (non-dosage forms) (9273). II Morphine (9300). II Oripavine (9330). II Thebaine (9333). II Oxymorphone (9652). II Phenazocine (9715). II Fentanyl (9801). II-The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research. No comments or objections have been received. DEA has considered the factors in 21 ...
URL: http://edocket.access.gpo.gov/2010/2010-4403.htm

... classes of controlled substances listed in schedules I and II:-Drug Schedule-Dihydromorphine (9145). I Amphetamine (1100). II Methamphetamine (1105). II Amobarbital (2125). II Pentobarbital (2270). II Secobarbital (2315). II Phenylacetone (8501). II Cocaine (9041). II Codeine (9050). II Dihydrocodeine (9120). II Oxycodone (9143). II Hydromorphone (9150). II Diphenoxylate (9170). II Ecgonine (9180). II Hydrocodone (9193). II Meperidine (9230). II Methadone (9250). II Morphine (9300). II Oxymorphone (9652). II Alfentanil (9737). II Remifentanil (9739). II Sufentanil (9740). II Fentanyl (9801). II-The company plans on manufacturing the listed controlled substances in bulk for sale to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823 (a) and determined that the registration of Cody Laboratories ...
URL: http://edocket.access.gpo.gov/2010/2010-511.htm

... (2010). I Tetrahydrocannabinols (7370). I Dihydromorphine (9145). I Difenoxin (9168). I Propiram (9649). I Amphetamine (1100). II Methamphetamine (1105). II Lisdexamfetamine (1205). II Methylphenidate (1724). II Nabilone (7379). II Cocaine (9041). II Codeine (9050). II Dihydrocodeine (9120). II Oxycodone (9143). II Hydromorphone (9150). II Ecgonine (9180). II Hydrocodone (9193). II Meperidine (9230). II Methadone (9250). II Methadone intermediate (9254). II Morphine (9300). II Thebaine (9333). II Oxymorphone (9652). II Noroxymorphone (9668). II Alfentanil (9737). II Remifentanil (9739). II Sufentanil (9740). II Fentanyl (9801). II-The company plans to manufacture the listed controlled substances in bulk for sale to its customers. No comments or objections have been received. DEA has considered the factors in ...
URL: http://edocket.access.gpo.gov/2010/2010-4404.htm

... 08070, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances in schedules I and II: [[ Page 14190 ]]-Drug Schedule-Dihydromorphine (9145). I Amphetamine (1100). II Methylphenidate (1724). II Amobarbital (2125). II Pentobarbital (2270). II Secobarbital (2315). II Glutethimide (2550). II Codeine (9050). II Oxycodone (9143). II Hydromorphone (9150). II Hydrocodone (9193). II Methadone (9250). II Methadone intermediate (9254). II Dextropropoxyphene, bulk (non-dosage forms) II (9273). Morphine (9300). II Oripavine (9330). II Oxymorphone (9652). II-The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 ...
URL: http://edocket.access.gpo.gov/2010/2010-6420.htm

... ). II Methamphetamine (1105). II Methylphenidate (1724). II Amobarbital (2125). II Pentobarbital (2270). II Secobarbital (2315). II Glutethimide (2550). II Nabilone (7379). II Phencyclidine (7471). II Cocaine (9041). II Codeine (9050). II Diprenorphine (9058). II Oxycodone (9143). II Hydromorphone (9150). II Diphenoxylate (9170). II Ecgonine (9180). II Ethylmorphine (9190). II Hydrocodone (9193). II Levorphanol (9220). II Meperidine (9230). II Methadone (9250). II Morphine (9300). II Thebaine (9333). II Opium, powdered (9639). II Levo-alphacetylmethadol (9648). II Oxymorphone (9652). II Fentanyl (9801). II-The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. ...
URL: http://edocket.access.gpo.gov/2010/2010-6444.htm

... ). II Methamphetamine (1105). II Methylphenidate (1724). II Amobarbital (2125). II Pentobarbital (2270). II Secobarbital (2315). II Glutethimide (2550). II Nabilone (7379). II Phencyclidine (7471). II Cocaine (9041). II Codeine (9050). II Diprenorphine (9058). II Oxycodone (9143). II Hydromorphone (9150). II Diphenoxylate (9170). II Ecgonine (9180). II Ethylmorphine (9190). II Hydrocodone (9193). II Levorphanol (9220). II Meperidine (9230). II Methadone (9250). II Morphine (9300). II Thebaine (9333). II Opium, powdered (9639). II Levo-alphacetylmethadol (9648). II Oxymorphone (9652). II Fentanyl (9801). II-The company plans to import the listed controlled substances for sale to [[ Page 36694 ]] research facilities for drug testing and analysis. No comments or objections have been received. DEA has considered the factors in ...
URL: http://edocket.access.gpo.gov/2010/2010-15557.htm

Result Pages: 1 2 Next >>

 

FindingHealthOnline is sponsored by and © 2010 Betterchem.com
Better Chemistry… Better Health